✦ LIBER ✦

Effective treatment of advanced solid tumors by the combination of arsenic trioxide and L-buthionine-sulfoximine

✍ Scribed by Maeda, H; Hori, S; Ohizumi, H; Segawa, T; Kakehi, Y; Ogawa, O; Kakizuka, A

Book ID: 118676696
Publisher: Nature Publishing Group
Year: 2004
Tongue: English
Weight: 318 KB
Volume: 11
Category: Article
ISSN: 1350-9047
DOI: 10.1038/sj.cdd.4401389

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cytotoxic effects of glutathione synthes

Cytotoxic effects of glutathione synthesis inhibition by L-buthionine-(SR)-sulfoximine on human and murine tumor cells

✍ Robert T. Dorr; James D. Liddil; Michelle J. Soble 📂 Article 📅 1986 🏛 Springer US 🌐 English ⚖ 601 KB

The glutathione (GSH) synthesis inhibitor, buthionine sulfoximine (BSO) was tested for cytotoxicity and thiol depletion in murine and human tumor cells in vitro, and for its antitumor activity and toxicity in vivo. The cell lines used in these studies included murine L-1210 leukemia, human RPMI 8226

Effective depletion of glutathione in ra

Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-one

✍ Erik Pileblad; Tor Magnusson 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 649 KB

Effective targeting of chronic myeloid l

Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha

✍ El Eit, Rabab M.; Iskandarani, Ahmad N.; Saliba, Jessica L.; Jabbour, Mark N.; M 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 French ⚖ 544 KB

Effect of 1,25-dihydroxyvitamin D3 on cu

Effect of 1,25-dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine

✍ Kazuyoshi Shinpo; Seiji Kikuchi; Hidenao Sasaki; Fumio Moriwaka; Kunio Tashiro 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 260 KB 👁 1 views

Overcoming tumor necrosis factor-α resis

Overcoming tumor necrosis factor-α resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-α. Role of tumor necrosis factor-α mRNA down-regulation in tumor cell sensitization

✍ Youichi Mizutani; Osamu Yoshida 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 871 KB

Phase I trial of olaparib in combination

Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors

✍ Balmana, J.; Tung, N. M.; Isakoff, S. J.; Grana, B.; Ryan, P. D.; Saura, C.; Low 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 144 KB